Posizolid
Clinical data | |
---|---|
ATC code | none |
Identifiers | |
| |
Synonyms | AZD2563 |
CAS Number | 252260-02-9 |
PubChem (CID) | 213049 |
ChemSpider | 184741 |
UNII | 82V2M8K24R |
ECHA InfoCard | 100.234.485 |
Chemical and physical data | |
Formula | C21H21F2N3O7 |
Molar mass | 465.40 g/mol |
3D model (Jmol) | Interactive image |
| |
| |
(what is this?) (verify) |
Posizolid is an oxazolidinone antibiotic under investigation by AstraZeneca for the treatment of bacterial infections. At a concentration of 2 mg/L it inhibited 98% of all Gram-positive bacteria tested in vitro.[1]
References
- ↑ Wookey, A.; Turner, P. J.; Greenhalgh, J. M.; Eastwood, M.; Clarke, J.; Sefton, C. (2004). "AZD2563, a novel oxazolidinone: definition of antibacterial spectrum, assessment of bactericidal potential and the impact of miscellaneous factors on activity in vitro". Clinical Microbiology and Infection. 10 (3): 247–254. doi:10.1111/j.1198-743X.2004.00770.x. PMID 15008947.
This article is issued from Wikipedia - version of the 10/28/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.